CIK: 0001674712 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $705,919 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Menlo Therapeutics | 4,011,236 | $150,742 | 21.4% | $37.58 | — | Common | 586858102 |
| ASND | Ascendis Pharma | 2,166,832 | $141,711 | 20.1% | $26.35 | — | ADR | 04351P101 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 2,049,545 | $52,796 | 7.5% | $36.97 | — | Common | G11196105 |
| CDXS | Codexis, Inc. | 3,054,825 | $33,603 | 4.8% | $3.85 | +148.4% | Common | 192005106 |
| APLS | Apellis Pharmaceuticals, Inc. | 1,457,834 | $32,233 | 4.6% | $14.72 | +33.5% | Common | 03753U106 |
| — | Verona Pharma Plc | 1,492,951 | $29,859 | 4.2% | $13.61 | — | ADS | 925050106 |
| ACRS | Aclaris Therapeutics | 1,647,214 | $28,859 | 4.1% | $19.11 | +10.9% | Common | 00461U105 |
| — | Homology Medicines, Inc. | 1,159,742 | $21,687 | 3.1% | $18.70 | — | Common | 438083107 |
| — | Nabriva Therapeutics Plc | 4,074,190 | $20,493 | 2.9% | $8.19 | — | SHS | G63637105 |
| — | Amyris, Inc. | 2,826,711 | $18,911 | 2.7% | $3.20 | — | Common | 03236M200 |
| — | Eiger BioPharmaceuticals | 1,791,257 | $17,644 | 2.5% | $16.42 | — | Common | 28249U105 |
| — | Strongbridge Biopharma plc | 1,918,132 | $16,975 | 2.4% | $2.40 | — | SHS USD | G85347105 |
| — | Kala Pharmaceuticals, Inc. | 1,043,020 | $16,511 | 2.3% | $22.84 | — | Common | 483119103 |
| — | Kadmon Holdings (KDMN) | 3,333,333 | $14,167 | 2.0% | $3.35 | — | Common | 48283N106 |
| ARWR | Arrowhead Pharmaceuticals Inc | 1,900,000 | $13,699 | 1.9% | $6.16 | 0.0% | Common | 04280A100 |
| — | Selecta Biosciences, Inc. | 1,119,189 | $11,405 | 1.6% | $19.86 | — | Common | 816212104 |
| — | Cymabay Therapeutics Inc | 800,000 | $10,392 | 1.5% | $12.99 | — | Common | 23257D103 |
| — | Aimmune Therapeutics, Inc. | 306,872 | $9,768 | 1.4% | $10.99 | — | Common | 00900T107 |
| — | Genocea Biosciences Inc | 8,180,000 | $8,589 | 1.2% | $1.05 | — | Common | 372427104 |
| — | Soleno Therapeutics, Inc. | 4,033,534 | $7,313 | 1.0% | $1.80 | — | Common | 834203200 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,213,290 | $6,297 | 0.9% | $5.62 | -4.8% | Common | 05156V102 |
| ZLAB | Zai Lab LTD | 283,787 | $6,059 | 0.9% | $27.00 | — | ADR | 98887Q104 |
| — | Sierra Oncology, Inc | 2,438,270 | $5,047 | 0.7% | $1.55 | — | Common | 82640U107 |
| RGNX | Regenxbio Inc. | 164,403 | $4,907 | 0.7% | $12.80 | +127.4% | Common | 75901B107 |
| — | Foamix Pharmaceuticals Ltd. | 855,000 | $4,386 | 0.6% | $9.26 | — | SHS | M46135105 |
| — | Zogenix, Inc. | 105,000 | $4,205 | 0.6% | $40.05 | — | Common | 98978L204 |
| — | Agile Therapeutics, Inc. | 1,513,975 | $3,891 | 0.6% | $6.21 | — | Common | 00847L100 |
| — | BioPharmX Corporation | 16,128,515 | $3,726 | 0.5% | $0.36 | — | Common | 09072X101 |
| MDGL | Madrigal Pharmaceuticals Inc | 27,220 | $3,179 | 0.5% | $123.44 | 0.0% | Common | 558868105 |
| KALV | KalVista Pharmaceuticals, Inc. | 300,325 | $2,847 | 0.4% | $7.13 | +46.9% | Common | 483497103 |
| — | Trevena, Inc. | 1,728,000 | $2,834 | 0.4% | $7.67 | — | Common | 89532E109 |
| — | Akari Therapeutics Plc | 345,850 | $629 | 0.1% | $14.00 | — | ADR | 00972G108 |
| — | Sunesis Pharmaceuticals, Inc. | 195,474 | $532 | 0.1% | $3.62 | — | Common Par | 867328700 |
| — | Soleno Therapeutics, Inc. | 188,772 | $23 | 0.0% | $0.14 | — | Warrant | 834203135 |